Soligenix to work with University of Hawaii, Hawaii Biotech on Ebola; Medigene's dendritic cell vaccines receive patent extention;

> Princeton, NJ-based Soligenix inked a collaboration agreement with the University of Hawaii at Manoa and Hawaii Biotech to work on a heat stable Ebola vaccine. Release

> The U.S. Patent Office extended Medigene's patent for dendritic cell vaccines to 2031. Brief

> Noting a potential for a hypertension vaccine, researchers found in a study of rats that three needless injections delivered lowered blood pressure for up to six months. More

> Research published in mBio suggests a protein called Niemann-Pick C1 to be the "Achilles' heel" of Ebola. More

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.